跳至主要内容
临床试验/NCT03457831
NCT03457831招募中不适用

Status Epilepticus in the Critically Ill Patients

Ictal Group20 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2018年2月28日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Ictal Group
入组人数
1,000
试验地点
20
主要终点
Favorable outcome

研究概览

简要总结

Convulsive and Non Convulsive Status Epilepticus (SE) and Pseudo Status Epilepticus prospective registry.

Data collection using a standardized form : demographic data and data related to the SE, including circumstances of onset, dates and times of onset and of seizure control, on-scene clinical findings, clinical features of the seizures, pre-hospital and hospital care providers, timing of antiepileptic and supportive treatments, results of etiological investigations, cause of SE, type and dosage of antiepileptic drugs. Dates and times of EEG monitoring, EEG results. Outcomes including vital status and Glasgow Outcome Scale score at ICU and hospital discharge, day-90 and 1-year after SE and determined based on data in the ICU and/or neurologist charts and/or patients phone interview.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • SE defined as 5 min or more of (i) continuous clinical and/or electrographic seizure activity or (ii) recurrent seizure activity without recovery (returning to baseline) between seizures.
  • age >= 18 years

排除标准

  • age < 18 years
  • postanoxic status epilepticus

结局指标

主要结局

Favorable outcome

时间窗: 1 year

A favorable outcome is defined by a Glasgow Outcome Scale (GOS) of 5. The Glasgow Outcome Scale (GOS) will be determined according to patients charts review and/or general practitioner interview conducted by an independent assessor. The GOS score : \[1: Death, 2: Persistent vegetative state, 3: Severe disability, 4: Moderate disability, 5 : Low disability\]

次要结局

  • refractory status epilepticus(24 hours)
  • super refractory status epilepticus(72 hours)
  • total ICU and in-hospital length of stay(90 days)
  • mortality rate(ICU and hospital discharge, 3-months, and 1-year, 5 years and 10 years)
  • Favorable outcome(3 months, 5-years and 10 years)
  • Functional impairment(3 months, and 1-year, 5-years and 10-years)
  • total seizure duration(72 hours)
  • percentages of the patients that experience recurrent convulsive and/or non-convulsive seizures within 12 hours after ICU admission(12 hours)

研究者

发起方
Ictal Group
申办方类型
Other
责任方
Sponsor

研究点 (20)

Loading locations...

相似试验